Spartan Capital

Spartan Capital appears on the underwriting syndicate of 1 special purpose acquisition company IPO in our index, including Aimei Health Technology Co., Ltd. (AFJK). The full list, with the role credited on each cover page, is in the mandates table on this page.

Spartan Capital was credited as a book-running manager on 1 of its 1 SPAC mandates, 100% of them. The remainder are co-manager or syndicate positions, where the economics and the sponsor relationship sit elsewhere.

$12.5M of gross proceeds across every offering Spartan Capital was named on. That is the conventional league-table measure, which credits the full deal to each syndicate member. The narrower figure is its own allocation: $59.5M, being the units the underwriting agreements assigned to Spartan Capital specifically, priced at the $10 standard SPAC unit.

Aimei Health Technology Co., Ltd. (AFJK), which raised $12.5M in Dec 2023. Spartan Capital was credited as a book-running manager on that offering.

None of the SPACs Spartan Capital underwrote has yet reported a completed business combination in the filings we index. 1 remain live and 0 returned their trust.

1 vehicles Spartan Capital took public are still live, either searching or working towards an announced combination: Aimei Health Technology Co., Ltd. (AFJK). Their combination deadlines are on each profile.

None of Spartan Capital's SPAC mandates has resolved yet, so a completion rate would be meaningless. It is left blank rather than shown as zero.

We hold a current quote for none of Spartan Capital's closed deals, so no comparison is possible here. Post-merger price history is not part of our dataset, and we would rather say so than imply a ranking the data does not support. What this page does show is the outcome of every vehicle and the trust economics disclosed at the time.

Aimei (1 deal). Sponsor franchises are resolved from the sponsor entity named in each prospectus, so repeat issuers group together even though every vehicle is a separate legal entity.

Most often B. Riley Securities (1). Syndicate composition is read from the prospectus cover and the underwriting section, so these are co-appearances on the same offering, not a commercial relationship we have any other visibility into.

Its first SPAC IPO in our index priced Dec 5, 2023 and the most recent Dec 5, 2023. 1 of its vehicles are still live, so the franchise is active.

The average offering it has been named on raised $12.5M, against a range from $12.5M to $12.5M. Deal size is a reasonable proxy for where a house sits in the market: the bulge bracket concentrates on larger trusts, the SPAC specialists on smaller ones.

Technology (1) and Healthcare (1). Mandates are read from charter language in the prospectus and are often deliberately broad. Many SPACs reserve the right to pursue any industry, in which case no sector is tagged at all.

Nasdaq (1). Listing venue is taken from the exchange record on the registrant's SEC profile.

None in our index. Either its vehicles closed a deal or they are still inside their combination window.

Every figure is read from filings the registrants made with the SEC. Syndicate membership and role come from the prospectus cover and the underwriting section of each IPO prospectus (Form 424B4); outcomes come from the filing record: a current report announcing completion, or a delisting notice ending a liquidation. Nothing here is sourced from press coverage or from Spartan Capital itself.